tirzepatide off the shortage list Eli Lilly's is FDA's drug list: Here's what it means Drugmakers battle pharmacies over compounded

Novo Nordisk published a cross-trial comparison claiming its Wegovy pill produced greater weight loss than Eli Lilly $LLY's newly approved obesity tablet Foundayo, raising the stakes as the two companies compete to shape prescribing trends in the oral GLP-1 market.

This integration further streamlines access to the only approved dual GIP and GLP-1 receptor agonist without patients ever having to leave the Ro app, let alone leave their home," said Zach Reitano, co-founder & CEO of Ro in a statement

(10:45) The dose matters

The regulatory role of DPP4 in atherosclerotic disease

Some biologics like TNF inhibitors may interact with GLP-1 signaling pathways, though direct contraindications remain rare in current literature